Geneesmiddelenbeleid
This procedure concerns a motion regarding the national policy for medicines. It aims to address how pharmaceutical products are managed, priced, or accessed within the healthcare system to ensure sustainable and effective patient care. This affects healthcare providers, pharmaceutical companies, and patients who rely on the availability and affordability of essential medications.
National vote coverage: Netherlands-only